TP53 Somatic Mutation, Prognostic
Test Code
Clinical Significance
TP53 Somatic Mutation, Prognostic - Somatic mutation of the p53 tumor suppressor gene is the most common genetic alteration seen in human cancers, with >50% of adult human tumors bearing inactivating mutations or insertions, deletions in the P53 gene. Wild type p53 prevents genetic instability and participates in the apoptotic response to radiotherapy and chemotherapy. Mutations in P53 gene usually correlate with poor outcome and early recurrence in cancer. This test provides important prognostic and prodictive information for patients with B-CLL, breast cancer, cervical cancer, melanoma or other cancers.
Test Resources
Test Summary
AML Rapid Mutation PanelTest Details
Methodology
Reference Range(s)
Preferred Specimen(s)
6 mL whole blood collected in an EDTA (lavender-top) tube
Alternative Specimen(s)
Formalin-fixed paraffin embedded tissue submitted in paraffin embedded tissue block • 3 mL bone marrow collected in an EDTA (lavender-top) tube
Collection Instructions
Follow standard whole blood collection procedure. Collect 5-6 mL whole blood samples in an EDTA tube. Blood samples are shipped at room temperature or 4° C. Do not freeze whole blood. Record the draw time and sample type on the tube, or block ID on requisition form. Ship immediately to maintain sample stability.
Transport Container
EDTA (lavender-top) tube
Transport Temperature
Refrigerated (cold packs)
Specimen Stability
Whole blood or bone marrow
- Room temperature: 72 hours
- Refrigerated: 7 days
- Frozen: Unacceptable
- Formalin-fixed paraffin embedded tissue
- Room temperature: Indefinite
- Refrigerated: Indefinite
- Frozen: Unacceptable
Reject Criteria
Received frozen
Setup Schedule, Minimum Volume
Whole blood or bone marrow
Room temperature: 72 hours
Refrigerated: 7 days
Frozen: Unacceptable
Formalin-fixed paraffin embedded tissue
Room temperature: Indefinite
Refrigerated: Indefinite
Frozen: Unacceptable
Received frozen